Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 234,786 | 178,554 | 182,915 | 152,732 | 130,688 |
| Cost of Goods | 46,262 | 34,081 | 40,309 | 24,125 | 31,603 |
| Gross Profit | 188,524 | 144,473 | 142,606 | 128,607 | 99,085 |
| Operating Expenses | 148,636 | 114,627 | 109,822 | 90,704 | 88,352 |
| Operating Income | 40,150 | 29,927 | 33,093 | 38,028 | 11,336 |
| Interest Expense | 7 | 47 | 71 | 1,152 | 767 |
| Other Income | 1,368 | 2,133 | 2,965 | 1,139 | 10,540 |
| Pre-tax Income | 41,511 | 32,013 | 35,987 | 38,015 | 21,109 |
| Income Tax | 14,966 | 12,055 | 13,051 | 15,222 | 5,325 |
| Net Income Continuous | 26,545 | 19,958 | 22,936 | 22,793 | 15,784 |
| Minority Interests | -4,599 | -724 | N/A | N/A | N/A |
| Net Income | $31,144 | $20,682 | $22,936 | $22,793 | $15,784 |
| EPS Basic Total Ops | 1.02 | 0.69 | 0.79 | 0.99 | 0.77 |
| EPS Basic Continuous Ops | 0.87 | 0.67 | 0.79 | 0.99 | 0.77 |
| EPS Diluted Total Ops | 0.99 | 0.68 | 0.77 | 0.93 | 0.69 |
| EPS Diluted Continuous Ops | 0.85 | 0.66 | 0.77 | 0.93 | 0.69 |
| EBITDA(a) | $45,149 | $34,891 | $37,910 | $42,743 | $14,885 |